Using Network Pharmacology to Explore the Mechanism of Panax notoginseng in the Treatment of Myocardial Fibrosis

Figure 7

Molecular docking simulation of bioactive compound-key target: (a) IL6-dihydrorutaecarpine; (b) ALB-rutaecarpine; (c) AKT1-rutaecarpine; (d) TNF-rutaecarpine; (e) VEGFA-ginsenoside Rb1.

(a)

(b)

(c)

(d)

(e)